Experts highlighted the importance of early autism diagnosis and intervention, addressing access barriers, disparities in care, and the development of new tools to improve early detection.

Prescription digital therapeutics represent the evolving intersection of technology and mental health care – but how do clinicians feel about this new era?

The Council of Autism Service Providers has updated the applied behavior analysis practice guidelines for the treatment of autism spectrum disorder.

Hallucinogens are being evaluated in Phase 2 and Phase 3 clinical trials for their therapeutic potential to treat a wide variety of mental health disorders.

Some individuals with ASD learn to use certain behaviors to minimize or conceal their symptoms so they can be perceived as neurotypical. The term “masking” (also referred to as “camouflaging") is used to describe these coping strategies.